Pharma & Biotech

Shares of Aclaris Therapeutics experienced a notable advance today, climbing more than 3.5 percent. This upward movement comes directly on...

Biotechnology firm Ocugen approaches a pivotal moment that could define its trajectory for the coming year. The company's presentation at...

Shares of Voyager Therapeutics have registered notable gains after a series of presentations at investor conferences. The biotechnology company's stock...

Shares of Monopar Therapeutics experienced a significant rally, propelled by encouraging clinical trial developments and a wave of positive analyst...

The biotechnology firm G1 Therapeutics has ceased to be a publicly traded entity following its successful acquisition by the Danish...

Vanda Pharmaceuticals Inc. (Vanda) provided a comprehensive update on its strategic direction and drug development pipeline during the Cantor Global...

Keros Therapeutics Inc (NASDAQ: KROS) is drawing significant market attention as CEO Jasbir Seehra prepares to present at the Wells...

Myriad Genetics has announced compelling new clinical evidence supporting its GeneSight Psychotropic test. A comprehensive meta-analysis released yesterday, which included...

QuidelOrtho shares closed Wednesday's session at $27.61, marking a decline of 2.27%. This downward movement occurred even as RBC Capital...

At the recent Wells Fargo Healthcare Conference, Vertex Pharmaceuticals CEO Reshma Kewalramani underscored the profound strategic importance of the company's...